Isthmus Partners’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.49M Sell
18,965
-4,629
-20% -$592K 0.24% 104
2026
Q2
$4.47M Sell
23,594
-15,763
-40% -$2.34M 0.43% 65
2026
Q1
$3.66M Sell
39,357
-2,123
-5% -$188K 0.38% 65
2025
Q4
$3.33M Sell
41,480
-536
-1% -$44.9K 0.37% 70
2025
Q3
$4.1K Buy
42,016
+7,848
+23% +$632K ﹤0.01% 148
2025
Q2
$2.38M Buy
34,168
+2,547
+8% +$145K 0.28% 89
2025
Q1
$1.57M Buy
31,621
+3,330
+12% +$211K 0.2% 101
2024
Q4
$1.98M Buy
28,291
+507
+2% +$42.1K 0.24% 99
2024
Q3
$2.91M Sell
27,784
-5,486
-16% -$642K 0.35% 79
2024
Q2
$4.73M Buy
33,270
+15,507
+87% +$1.79M 0.56% 52
2024
Q1
$1.98M Buy
+17,763
New +$2.12M 0.22% 105

Other funds holding ACLS

Isthmus Partners's ACLS Position: Q3 2026 in Review

Isthmus Partners reduced its Axcelis (ACLS) stake by 20% in Q3 2026, selling an estimated $592K and leaving 18,965 shares worth $2.49M. The position accounts for 0.24% of the portfolio, ranked #104.

Isthmus Partners first reported a position in ACLS in Q1 2024 and has held it in 11 quarters since. The position peaked at $4.73M in Q2 2024. 115 funds tracked by Wall St. Rank hold ACLS as of Q3 2026.

  • Isthmus Partners held 18,965 shares of Axcelis worth $2.49M as of Q3 2026.
  • Isthmus Partners sold 4,629 Axcelis shares in Q3 2026, an estimated $592K.
  • Axcelis made up 0.24% of Isthmus Partners's portfolio in Q3 2026, its #104 holding.
  • Isthmus Partners first reported a position in Axcelis in Q1 2024 and has held it in 11 quarters since.
  • Isthmus Partners's Axcelis position peaked at $4.73M in Q2 2024.
  • 115 funds tracked by Wall St. Rank held Axcelis as of Q3 2026.

Based on Isthmus Partners's 13F filing for Q3 2026, filed 21 Oct 2026.